Acetic Acid

Acetic Acid

SCHEMBL8893677

C=CC(=C)C(=O)O.CC(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
TSHR P16473 4/20 0.42
TP53 P04637 1/20 0.42
LMNA P02545 1/20 0.42
FFAR3 O14843 1/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
FGFR4 P22455 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL465616 0.91
SCHEMBL8981852 0.88
Ammonia Solution, Strong SCHEMBL11247031 0.88
Ethylene SCHEMBL2488792 0.88
Hydrochloric Acid SCHEMBL8012629 0.88
Butadiene SCHEMBL10734664 0.85 LMNA (0.44) ALDH1A1TSHRTP53LMNAALOX15
Acrylic Acid SCHEMBL2942899 0.85 LMNA (0.62) ALDH1A1TSHRTP53LMNAALOX15
Bicarbonate SCHEMBL28290875 0.85 LMNA (0.44) ALDH1A1TSHRTP53LMNAALOX15
Vinyl Chloride SCHEMBL27606793 0.82 LMNA (0.42) ALDH1A1TSHRLMNAALOX15HSD17B10
SCHEMBL28369427 0.78 ALDH1A1 (0.43) ALDH1A1TSHRLMNAALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10174170-B2 Method for producing liquid high-purity polyhydric alcohol derivative-modified silicone or composition thereof DOW CORNING TORAY CO., LTD. (JP) 2019-01-08 US disclosed
US-20170218130-A1 METHOD FOR PRODUCING LIQUID HIGH-PURITY POLYHYDRIC ALCOHOL DERIVATIVE-MODIFIED SILICONE OR COMPOSITION THEREOF DOW TORAY CO., LTD. (JP) 2017-08-03 US disclosed
EP-3147307-A1 METHOD FOR PRODUCING LIQUID HIGH-PURITY POLYHYDRIC ALCOHOL DERIVATIVE-MODIFIED SILICONE OR COMPOSITION THEREOF Dow Corning Toray Co., Ltd. (JP) 2017-03-29 EP disclosed
US-5672561-A RIBBON SUBSTRATE COATED WITH INK LAYER AREAS AND SEPARATELY DISPOSED RELEASING LAMINATE LAYER AREAS; HEAT RESISTANCE, UNIFORM TRANSFER SONY CORPORATION (JP) 1997-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10174170-B2 Method for producing liquid high-purity polyhydric alcohol derivative-modified silicone or composition thereof SAMM50, SORD, ADH1C ALDH1A1 945/4885TSHR 3860/4885TP53 633/4885
US-20170218130-A1 METHOD FOR PRODUCING LIQUID HIGH-PURITY POLYHYDRIC ALCOHOL DERIVATIVE-MODIFIED SILICONE OR COMPOSITION THEREOF SAMM50, SORD, ADH1C ALDH1A1 945/4885TSHR 3860/4885TP53 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.